Named on one round in the feed.
Since 2024-10-31
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$916K
across 1 round
CO-INVESTORS
3
named beside it
Named on one round in the feed.
Since 2024-10-31
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Celaid Therapeutics Inc. A biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs) | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $916K | 2024-10-31 | [ PART ] |